The American Journal of Medicine
Volume 118, Issue 12 , Pages 1414.e7-1414.e12 , December 2005

Bone mineral density in subjects using central nervous system-active medications

  • Mitsuyo Kinjo, MD, MPH

      Affiliations

    • Department of Internal Medicine, Teine Keijinkai Hospital, Sapporo, Japan
    • Corresponding Author InformationRequests for reprints should be addressed to Mitsuyo Kinjo, MD, MPH, Department of Internal Medicine, Teine Keijinkai Hospital, 1-40 Maeda 1 jou 12 chou-me, Teine-ku, Sapporo, Hokkaido, 006-8555 Japan
    • ,
  • Soko Setoguchi, MD, MPH, MS

      Affiliations

    • Division of Pharmacoepidemiology, Brigham and Women’s Hospital, Harvard Medical School, Mass
    • ,
  • Sebastian Schneeweiss, MD, ScD

      Affiliations

    • Division of Pharmacoepidemiology, Brigham and Women’s Hospital, Harvard Medical School, Mass
    • ,
  • Daniel H. Solomon, MD, MPH

      Affiliations

    • Division of Pharmacoepidemiology, Brigham and Women’s Hospital, Harvard Medical School, Mass

References 

  1. Cummings SR , Bates D , Black DM . Clinical use of bone densitometry (scientific review) . JAMA . 2002;288:1889–1897
  2. Kanis JA , Melton LJ , Christiansen C , Johnston CC , Khaltaev N . The diagnosis of osteoporosis . J Bone Miner Res . 1994;9:1137–1141
  3. Espallargues M , Sampietro-Colom L , Estrada MD , et al.   Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements (a systematic review of the literature) . Osteoporos Int . 2001;12:811–822
  4. Ray WA , Griffin MR , Schaffner W , Baugh DK , Melton LJ . Psychotropic drug use and the risk of hip fracture . N Engl J Med . 1987;316:363–369
  5. Allolio B . Risk factors for hip fracture not related to bone mass and their therapeutic implications . Osteoporos Int . 1999;9(Suppl 2):S9–S16
  6. Ensrud KE , Blackwell T , Mangione CM , et al.   Central nervous system active medications and risk for fractures in older women . Arch Intern Med . 2003;163:949–957
  7. Shorr RI , Griffin MR , Daugherty JR , Ray WA . Opioid analgesics and the risk of hip fracture in the elderly (codeine and propoxyphene) . J Gerontol . 1992;47:M111–M115
  8. Cumming RG , Le Couteur DG . Benzodiazepines and risk of hip fractures in older people (a review of the evidence) . central nervous system Drugs . 2003;17:825–837
  9. Liu B , Anderson G , Mittmann N , To T , Axcell T , Shear N . Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people . Lancet . 1998;351:1303–1307
  10. Ensrud KE , Blackwell TL , Mangione CM , et al.   Central nervous system-active medications and risk for falls in older women . J Am Geriatr Soc . 2002;50:1629–1637
  11. Guo Z , Wills P , Viitanen M , Fastbom J , Winblad B . Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old (a community-based prospective study) . Am J Epidemiol . 1998;148:887–892
  12. Leipzig RM , Cumming RG , Tinetti ME . Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs . J Am Geriatr Soc . 1999;47:30–39
  13. Farhat G , Yamout B , Mikati MA , Demirjian S , Sawaya R , El-Hajj Fuleihan G . Effect of antiepileptic drugs on bone density in ambulatory patients . Neurology . 2002;58:1348–1353
  14. Chung S , Ahn C . Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children . Brain Dev . 1994;16:382–385
  15. Erbayat Altay E , Serdaroglu A , Tumer L , Gucuyener K , Hasanoglu A . Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid . J Pediatr Endocrinol Metab . 2000;13:933–939
  16. Stephen LJ , McLellan AR , Harrison JH , et al.   Bone density and antiepileptic drugs (a case-controlled study) . Seizure . 1999;8:339–342
  17. Harden CL . Menopause and bone density issues for women with epilepsy . Neurology . 2003;61(6 Suppl 2):S16–S22
  18. Andress DL , Ozuna J , Tirschwell D , et al.   Antiepileptic drug-induced bone loss in young male patients who have seizures . Arch Neurol . 2002;59:781–786
  19. Pack AM , Olarte LS , Morrell MJ , Flaster E , Resor SR , Shane E . Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs . Epilepsy Behav . 2003;4:169–174
  20. Daniell HW . Opioid osteoporosis . Arch Intern Med . 2004;164:338; ; author reply 338
  21. National Center for Health Statistics . Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994 . Vol. Washington, DC: Publication PHS; 1994; U.S. Department of Health and Human Services
  22. Looker AC , Johnston CC , Wahner HW , et al.   Prevalence of low femoral bone density in older U.S. women from NHANES III . J Bone Miner Res . 1995;10:796–802
  23. Looker AC , Orwoll ES , Johnston CC , et al.   Prevalence of low femoral bone density in older U.S. adults from NHANES III . J Bone Miner Res . 1997;12:1761–1768
  24. In:  Denniston PL ,  Epner JA editor. Physicians GenRx, (1994) (The Official Drug Reference) . Smithtown, NY: Data Pharmaceutica Inc; 1993;
  25. American Hospital Formulary Service . Drug Information 96 . Bethesda, MD: American Society of Health-System Pharmacists, Inc; 1996;
  26. Charlson ME , Pompei P , Ales KL , MacKenzie CR . A new method of classifying prognostic comorbidity in longitudinal studies (development and validation) . J Chronic Dis . 1987;40:373–383
  27. Nelson KM , Reiber G , Boyko EJ , NHANES III . Diet and exercise among adults with type 2 diabetes (findings from the third national health and nutrition examination survey (NHANES III)) . Diabetes Care . 2002;25:1722–1728
  28. Compendium of physical activities (an update of activity codes and MET intensities) . Med Sci Sports Exerc . 2000;32(9 Suppl):S498–S504
  29. Ensrud KE , Walczak TS , Blackwell T , Ensrud ER , Bowman PJ , Stone KL . Antiepileptic drug use increases rates of bone loss in older women (a prospective study) . Neurology . 2004;62:2051–2057
  30. Wahner HW , Looker A , Dunn WL , Walters LC , Hauser MF , Novak C . Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers . J Bone Miner Res . 1994;9:951–960
  31. Kubota F , Kifune A , Shibata N , et al.   Bone mineral density of epileptic patients on long-term antiepileptic drug therapy (a quantitative digital radiography study) . Epilepsy Res . 1999;33:93–97
  32. Akin R , Okutan V , Sarici U , Altunbas A , Gokcay E . Evaluation of bone mineral density in children receiving antiepileptic drugs . Pediatr Neurol . 1998;19:129–131
  33. Ali II , Schuh L , Barkley GL , Gates JR . Antiepileptic drugs and reduced bone mineral density . Epilepsy Behav . 2004;5:296–300
  34. Sato Y , Kondo I , Ishida S , et al.   Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy . Neurology . 2001;57:445–449
  35. Ohishi T , Kushida K , Takahashi M , et al.   Urinary bone resorption markers in patients with metabolic bone disorders . Bone . 1994;15:15–20
  36. Sheth RD . Bone health in epilepsy . Epilepsia . 2002;43:1453–1454
  37. Pack AM , Morrell MJ . Adverse effects of antiepileptic drugs on bone structure (epidemiology, mechanisms and therapeutic implications) . central nervous system Drugs . 2001;15:633–642
  38. Feldkamp J , Becker A , Witte OW , Scharff D , Scherbaum WA . Long-term anticonvulsant therapy leads to low bone mineral density—evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells . Exp Clin Endocrinol Diabetes . 2000;108:37–43
  39. Finch PM , Roberts LJ , Price L , Hadlow NC , Pullan PT . Hypogonadism in patients treated with intrathecal morphine . Clin J Pain . 2000;16:251–254
  40. Perez-Castrillon JL , Olmos JM , Gomez JJ , et al.   Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells . Neuroendocrinology . 2000;72:187–194
  41. Michelson D , Stratakis C , Hill L , et al.   Bone mineral density in women with depression . N Engl J Med . 1996;335:1176–1181
  42. Whooley MA , Kip KE , Cauley JA , Ensrud KE , Nevitt MC , Browner WS . Depression, falls, and risk of fracture in older women (Study of Osteoporotic Fractures Research Group) . Arch Intern Med . 1999;159:484–490
  43. Cizza G , Ravn P , Chrousos GP , Gold PW . Depression (a major, unrecognized risk factor for osteoporosis?) . Trends Endocrinol Metab . 2001;12:198–203
  44. Vrkljan M , Thaller V , Lovricevic I , et al.   Depressive disorder as possible risk factor of osteoporosis . Coll Antropol . 2001;25:485–492
  45. Robbins J , Hirsch C , Whitmer R , Cauley J , Harris T . The association of bone mineral density and depression in an older population . J Am Geriatr Soc . 2001;49:732–736
  46. Mussolino ME , Jonas BS , Looker AC . Depression and bone mineral density in young adults (results from NHANES III) . Psychosom Med . 2004;66:533–537
  47. Bliziotes MM , Eshleman AJ , Zhang XW , Wiren KM . Neurotransmitter action in osteoblasts (expression of a functional system for serotonin receptor activation and reuptake) . Bone . 2001;29:477–486
  48. Battaglino R , Fu J , Spate U , et al.   Serotonin regulates osteoclast differentiation through its transporter . J Bone Miner Res . 2004;19:1420–1431
  49. Haney EM , Chan BKS , Lambert L , et al.   SSRI Use Is Associated with Lower bone mineral density Among Men . Abstract presentation . Seattle, Washington: Annual meeting of American Society of Bone Mineral Research; 2004; October
  50. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (DSM-III) . 3rd edn.. Washington, DC: American Psychiatric Association; 1980;
  51. Spitzer RL , Williams JB , Skodol AE . DSM-III (the major achievements and an overview) . Am J Psychiatry . 1980;137:151–164

PII: S0002-9343(05)00627-3

doi: 10.1016/j.amjmed.2005.07.033

The American Journal of Medicine
Volume 118, Issue 12 , Pages 1414.e7-1414.e12 , December 2005

Article Tools